Gryphon Financial Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $500K | Buy |
|
|||||
|
2025
Q1 | $542K | Buy |
|
|||||
|
2024
Q4 | $424K | Sell |
|
|||||
|
2024
Q3 | $869K | Buy |
|
|||||
|
2024
Q2 | $728K | Sell |
|
|||||
|
2024
Q1 | $653K | Sell |
|
|||||
|
2023
Q4 | $486K | Buy |
|
|||||
|
2023
Q3 | $544K | Sell |
|
|||||
|
2023
Q2 | $551K | Buy |
|
|||||
|
2023
Q1 | $485K | Buy |
|
|||||
|
2022
Q4 | $443K | Sell |
|
|||||
|
2022
Q3 | $445K | Buy |
|
|||||
|
2022
Q2 | $428K | Sell |
|
|||||
|
2022
Q1 | $396K | Sell |
|
|||||
|
2021
Q4 | $350K | Sell |
|
|||||
|
2021
Q3 | $320K | Sell |
|
|||||
|
2021
Q2 | $503K | Buy |
|
|||||
|
2021
Q1 | $407K | Buy |
|
|||||
|
2020
Q4 | $446K | Sell |
|
|||||
|
2020
Q3 | $522K | Buy |
|
|||||
|
2020
Q2 | $548K | Sell |
|
|||||
|
2020
Q1 | $488K | Sell |
|
|||||
|
2019
Q4 | $478K | Buy |
|
|||||
|
2019
Q3 | $366K | Sell |
|
|||||
|
2019
Q2 | $397K | Sell |
|
|||||
|
2019
Q1 | $399K | Sell |
|
|||||
|
2018
Q4 | $361K | Sell |
|
|||||
|
2018
Q3 | $427K | Buy |
|
|||||
|
2018
Q2 | $40K | Sell |
|
|||||
|
2018
Q1 | $41K | Buy |
|
|||||
|
2017
Q4 | $37K | Buy |
|